We are live on ! Find out more
HQL

abrdn Life Sciences Investors
HQL

62 hedge funds and large institutions have $82.2M invested in abrdn Life Sciences Investors in 2020 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 29 increasing their positions, 11 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

164% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 11

1% more capital invested

Capital invested by funds: $81.3M → $82.2M (+$844K)

0.6% more ownership

Funds ownership: 19.28% → 19.87% (+0.6%)

11% less funds holding

Funds holding: 70 → 62 (-8)

54% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 13

Holders
62
Holders Change
-8
Holders Change %
-11.43%
% of All Funds
1.25%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
6
Increased
29
Reduced
11
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
AAM
Advisors Asset Management
Colorado
+$1.18M
2
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$789K
3
Wells Fargo
Wells Fargo
California
+$728K
4
Ameriprise
Ameriprise
Minnesota
+$666K
5
UR
USCA RIA
Texas
+$626K

Top Sellers

1
KIM
Karpus Investment Management
New York
-$1.17M
2
AWM
AE Wealth Management
Kansas
-$679K
3
CRC
Curi RMB Capital
Illinois
-$661K
4
SS
Simplicity Solutions
Minnesota
-$588K
5
LCM
Landscape Capital Management
New Jersey
-$305K
Name Holding Trade Value Shares
Change 		Change in
Stake
NIM
1
Needham Investment Management
New York
$8.53M -$89.5K -5,000 -1%
Morgan Stanley
2
Morgan Stanley
New York
$7.83M +$499K +27,869 +7%
1832 Asset Management
3
1832 Asset Management
Ontario, Canada
$7.67M – – –
AAM
4
Advisors Asset Management
Colorado
$5.82M +$1.18M +65,723 +25%
MC
5
Matisse Capital
Oregon
$5.61M -$53K -2,957 -0.9%
FHA
6
Flagship Harbor Advisors
Massachusetts
$5.16M +$147K +8,235 +3%
Wells Fargo
7
Wells Fargo
California
$5.03M +$728K +40,659 +17%
Cohen & Steers
8
Cohen & Steers
New York
$4.57M – – –
Lazard Asset Management
9
Lazard Asset Management
New York
$3.59M +$213K +11,892 +6%
1CP
10
1607 Capital Partners
Virginia
$3.57M +$501K +27,964 +16%
Osaic Holdings
11
Osaic Holdings
Arizona
$2.35M +$166K +9,285 +7%
UBS Group
12
UBS Group
Switzerland
$1.75M +$117K +6,516 +7%
LPL Financial
13
LPL Financial
California
$1.74M +$121K +6,751 +7%
Invesco
14
Invesco
Georgia
$1.34M +$297K +16,572 +28%
Bank of America
15
Bank of America
North Carolina
$1.23M -$4.15K -232 -0.3%
AA
16
AQR Arbitrage
Connecticut
$1.23M +$324K +18,073 +35%
Ameriprise
17
Ameriprise
Minnesota
$1.14M +$666K +37,186 +137%
CRC
18
Curi RMB Capital
Illinois
$1.04M -$661K -36,938 -38%
CCP
19
Clough Capital Partners
Massachusetts
$1.04M +$344K +19,200 +48%
1WA
20
180 Wealth Advisors
Washington
$1.01M -$16.9K -943 -2%
RJA
21
Raymond James & Associates
Florida
$919K -$27.8K -1,554 -3%
Bank of Montreal
22
Bank of Montreal
Ontario, Canada
$792K +$789K +44,041 New
RJFSA
23
Raymond James Financial Services Advisors
Florida
$777K +$88.3K +4,932 +13%
Royal Bank of Canada
24
Royal Bank of Canada
Ontario, Canada
$715K +$163K +9,079 +29%
Janney Montgomery Scott
25
Janney Montgomery Scott
Pennsylvania
$696K -$24.1K -1,344 -3%
1
2 3

HQL Hedge Fund Activity: Q3 2020 in Review

62 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in abrdn Life Sciences Investors (HQL) for Q3 2020, worth a combined $82.2M — up 1% from $81.3M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of HQL and 6 opened new positions — a net loss of 7 holders — while 11 trimmed existing stakes and 29 added.

The largest buyer was Advisors Asset Management, adding an estimated $1.18M. The largest seller was Karpus Investment Management, exiting entirely with an estimated $1.17M sold.

  • 62 institutional investors held abrdn Life Sciences Investors (HQL) as of Q3 2020, down from 70 in Q2 2020.
  • Funds reported $82.2M of abrdn Life Sciences Investors stock for Q3 2020, up 1% quarter-over-quarter.
  • 6 funds opened new abrdn Life Sciences Investors positions in Q3 2020 and 13 closed out, a net change of -7 holders.
  • The largest abrdn Life Sciences Investors buyer in Q3 2020 was Advisors Asset Management, an estimated $1.18M added.
  • The largest abrdn Life Sciences Investors seller in Q3 2020 was Karpus Investment Management, an estimated $1.17M sold.

Based on aggregated 13F filings for Q3 2020.